245 related articles for article (PubMed ID: 23506903)
1. Solute carriers as drug targets: current use, clinical trials and prospective.
Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB
Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903
[TBL] [Abstract][Full Text] [Related]
2. Solute carriers (SLCs) in cancer.
El-Gebali S; Bentz S; Hediger MA; Anderle P
Mol Aspects Med; 2013; 34(2-3):719-34. PubMed ID: 23506905
[TBL] [Abstract][Full Text] [Related]
3. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
Fredriksson R; Nordström KJ; Stephansson O; Hägglund MG; Schiöth HB
FEBS Lett; 2008 Nov; 582(27):3811-6. PubMed ID: 18948099
[TBL] [Abstract][Full Text] [Related]
4. The solute carrier transporters and the brain: Physiological and pharmacological implications.
Hu C; Tao L; Cao X; Chen L
Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195
[TBL] [Abstract][Full Text] [Related]
5. Structural biology of solute carrier (SLC) membrane transport proteins.
Bai X; Moraes TF; Reithmeier RAF
Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895
[TBL] [Abstract][Full Text] [Related]
6. A substrate-based ontology for human solute carriers.
Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G
Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
Dvorak V; Superti-Furga G
Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
[TBL] [Abstract][Full Text] [Related]
9. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
10. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
11. A Call for Systematic Research on Solute Carriers.
César-Razquin A; Snijder B; Frappier-Brinton T; Isserlin R; Gyimesi G; Bai X; Reithmeier RA; Hepworth D; Hediger MA; Edwards AM; Superti-Furga G
Cell; 2015 Jul; 162(3):478-87. PubMed ID: 26232220
[TBL] [Abstract][Full Text] [Related]
12. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of localization of 78 solute carrier genes throughout the subsections of the rat gastrointestinal tract.
Cedernaes J; Olszewski PK; Almén MS; Stephansson O; Levine AS; Fredriksson R; Nylander O; Schiöth HB
Biochem Biophys Res Commun; 2011 Aug; 411(4):702-7. PubMed ID: 21781957
[TBL] [Abstract][Full Text] [Related]
14. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
15. Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.
Anand U; Parikh A; Ugwu MC; Agu RU
Future Med Chem; 2014; 6(12):1381-97. PubMed ID: 25329195
[TBL] [Abstract][Full Text] [Related]
16. Solute carriers (SLCs) identified and characterized from kidney transcriptome of golden mahseer (Tor putitora) (Fam: Cyprinidae).
Barat A; Sahoo PK; Kumar R; Pande V
Comp Biochem Physiol B Biochem Mol Biol; 2016 Oct; 200():54-61. PubMed ID: 27287540
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to the CNS and polymeric nanoparticulate carriers.
Costantino L
Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
[TBL] [Abstract][Full Text] [Related]
18. The role of membrane transporters in drug delivery to brain tumors.
Nies AT
Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
[TBL] [Abstract][Full Text] [Related]
19. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
